Systematic NT-proBNP and ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm, Sweden - STROKESTOP II "STROKESTOP II"

Recruiting

Phase N/A Results N/A

Summary of Purpose

The STROKESTOP II study is a proposed study to determine if the biomarker NT-proBNP together with single-lead ECG can be used as a primary population screening tool for silent atrial fibrillation, and builds on previous results from the STROKESTOP study.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 May 2016.

1 Apr 2016 16 Mar 2016 1 Apr 2023 1 Apr 2023 1 May 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample

Contacts